HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bleeding time and antiplatelet agents in normal volunteers.

Abstract
Clinical trials have shown that antiplatelet agents are effective in the prevention of thrombosis in arterial diseases and increase bleeding time. To compare the effects of three such drugs [acetylsalicylic acid (ASA) at two dose levels, ticlopidine and indobufen] on bleeding time, we performed a randomized cross-over study on 12 normal subjects. All received the four treatments (ASA 300 mg daily and 500 mg twice daily, ticlopidine 250 mg twice daily and indobufen 200 mg twice daily, each for 6 days plus one dose on day 7) in a sequential manner with a washout period of 15 days between the treatments. Bleeding time was measured using a Surgicut device (Ortho, Milan, Italy) before treatment, 2 and 24 h after the first administration, and before and 2, 24, 48 and 72 h after the last administration. ASA (at both doses) and indobufen quickly induced a significant prolongation of bleeding time, but the effect of indobufen soon wore off after the treatment was stopped, unlike that of ASA. In contrast, ticlopidine treatment prolonged bleeding time only after the first 24 h, and after 7 days the mean value was significantly higher than with ASA (both doses) and indobufen. This significant difference in bleeding time between ticlopidine and the other drugs was still present 48 h after the end of treatment.
AuthorsE M Pogliani, C Fowst, R Bregani, G Corneo
JournalInternational journal of clinical & laboratory research (Int J Clin Lab Res) Vol. 22 Issue 1 Pg. 58-61 ( 1992) ISSN: 0940-5437 [Print] Germany
PMID1633323 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Isoindoles
  • Phenylbutyrates
  • Platelet Aggregation Inhibitors
  • indobufen
  • Ticlopidine
  • Aspirin
Topics
  • Adolescent
  • Adult
  • Aspirin (administration & dosage, adverse effects)
  • Bleeding Time
  • Female
  • Humans
  • Isoindoles
  • Male
  • Phenylbutyrates (adverse effects, pharmacology)
  • Platelet Aggregation Inhibitors (pharmacology)
  • Reference Values
  • Ticlopidine (adverse effects, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: